Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Monica Wielgos"'
Autor:
Maissa Mhibik, Erika M Gaglione, David Eik, John Herrick, Janet Le, Inhye E Ahn, Christopher Chiu, Monica Wielgos-Bonvallet, Ida H Hiemstra, Esther CW Breij, Jenny Chen, Edward B Reilly, Pearlie K. Epling-Burnette, Edith Szafer Glusman, Clare Sun, Adrian Wiestner
Publikováno v:
Blood Advances.
Chronic lymphocytic leukemia (CLL) is an immunosuppressive disease characterized by increased infectious morbidity and inferior anti-tumor activity of immunotherapies. Targeted therapy with Bruton's tyrosine kinase inhibitors (BTKis), or the Bcl-2 in
Autor:
PK Epling-Burnette, Durga B Dandamudi, Iwona M Konieczna, Kelly M Calabrese, Monica Wielgos-Bonvallet, Christiaan Kweekel, Elke Gresnigt - van den Heuvel, Apurvasena Parikh, Tommy Li, Christopher W Chiu, Adam Chervin, Edward B Reilly, Edith Szafer-Glusman
Publikováno v:
Blood. 140:9283-9285
Autor:
Omar Jabado, Christopher Chiu, Matthew Loya, Manling Ma-Edmonds, David Soong, Anantharaman Muthuswamy, Mahesh Bachu, Nicole Bottrel, Han Si, Jimin Zhang, Monica Wielgos-Bonvallet, Julie Blædel, Erin Henitz, Brandon Higgs, Kate Sasser, Suzana Couto, Maria Jure-Kunkel, Mark Fereshteh
Publikováno v:
Blood. 140:6424-6425
Autor:
Jimin Zhang, Han Si, Monica Wielgos-Bonvallet, David Soong, Edith Szafer-Glusman, Herve Ghesquieres, Chan Y. Cheah, Lorenzo Falchi, Joshua Brody, Mariana Sacchi, Ali Rana, Brandon Higgs, Brian Elliot, Maria Jure-Kunkel, Christopher W. Chiu
Publikováno v:
Cancer Research. 83:3248-3248
Introduction: B-cell lymphoma is a heterogeneous disease with an unmet medical need for efficacious, well tolerated, off-the-shelf therapies that can combine with standard of care (SOC) regimens. Epcoritamab is an IgG1 bispecific antibody that simult
Publikováno v:
Clinical Cancer Research. 26:A31-A31
Background: Poly (ADP-ribose) polymerase (PARP) inhibitors have transformed treatment of ovarian cancer in the past decade. Most of the currently active PARP inhibitors have similar ability to inhibit PARP’s enzymatic activity. However, it has been
Autor:
Minglei Wang, Suravi Thomas, Gustavo Caetano-Anollés, Arshan Nasir, Liudmila S. Yafremava, Monica Wielgos, Jay E. Mittenthal
Publikováno v:
Frontiers in Genetics, Vol 4 (2013)
Frontiers in Genetics
Frontiers in Genetics
The nature and cause of the division of organisms in superkingdoms is not fully understood. Assuming that environment shapes physiology, here we construct a novel theoretical framework that helps identify general patterns of organism persistence. Thi